Celldex Therapeutics to Present at the Cantor Global Healthcare Conference
September 30 2019 - 4:01PM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that
Anthony Marucci, Co-founder, President and Chief Executive Officer,
and Tibor Keler, PhD, Cofounder, Executive Vice President and Chief
Scientific Officer, will present a corporate overview at the Cantor
Global Healthcare Conference on Friday, October 4, 2019 at 10:40
a.m. EDT in New York.
The live webcast will be available on the "Events &
Presentations" page of the "Investors & Media" section of the
Celldex website. A replay will be available for seven days
following the event.
About Celldex Therapeutics, Inc.Celldex is
developing targeted therapeutics to address devastating diseases
for which available treatments are inadequate. Our pipeline
includes immunotherapies and other targeted biologics derived from
a broad set of complementary technologies which have the ability to
engage the human immune system and/or directly inhibit tumors to
treat specific types of cancer or other diseases. Visit
www.celldex.com.
Company ContactSarah CavanaughSenior Vice
President, Corporate Affairs & AdministrationCelldex
Therapeutics, Inc.(781) 433-3161scavanaugh@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024